(Q44598064)

English

A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma

scientific article published in August 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1

object named as

Piotr Kuna

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

James R Joubert

2

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Louis A P M Greefhorst

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Helgo Magnussen

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

2182-2197

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980212-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980212-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980212-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980212-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980212-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of inhaled corticosteroids. New developments

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980212-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980212-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Budesonide treatment of moderate and severe asthma in children: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980212-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980212-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980212-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The problem of dose-response and therapeutic ratio of inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980212-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980212-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)80212-6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44598064&oldid=2029088358"